Planet Green Stock PLAG · Forecast & Analysis
Heads-up: USD Core Retail Sales m/m, Retail Sales m/m came in worse than expected for USD (45 h ago).
Heads-up: USD Initial Jobless Claims, Philadelphia Fed Manufacturing Index are due in 2 h (high impact). The outlook can shift noticeably around them.
The picture for Planet Green (PLAG) is neutral: subsidiary Taihe Bio extended its lactoferrin strategy with a new chewable-tablet rights deal, but with no price disclosed it cannot be scored. There is no price history yet for a technical read.
News situation · 1 items / 30 D
1 of 1 straight from the issuer or regulator
Outlook for Planet Green Holdings
Direction, typical moves and upcoming dates from our own price, news and calendar data, recalculated on every visit. An assessment, not investment advice.
What drives it
- Subsidiary Taihe Bio extended its lactoferrin strategy with a new chewable-tablet technology agreement.
- A joint SAMR application is pending to transfer the Chinese health food registration to Taihe Bio.
What argues against it
- No purchase price or financial terms were disclosed, so the deal's cost and return are unknown.
- The registration transfer remains subject to regulatory approval.
- Latest US retail sales came in worse than expected, a soft macro backdrop for small caps.
What would change the picture
- Approval or rejection of the SAMR registration transfer would settle the deal's main open question.
- Disclosure of the purchase price or financial terms would let the deal's impact be judged.
- High-impact US releases due shortly, from jobless claims to Core PCE, may shift the macro tone.
Coming up
- US: Jobless claims, Philadelphia Fed Manufacturing Index · expected 32.2, previous 20.9
- US: Michigan Consumer Sentiment · expected 51.0, previous 51.0
- US: CB Consumer Confidence Index · expected 91.5, previous 91.7
Economic data for PLAG
Full calendarRecently released
- November 18, 2026USDEIA Crude Oil Stocks Change●●●Actual 3.380MForecast -0.309MPrevious 4.657M
- November 17, 2026USDCore Retail Sales m/m●●●Actual 0.6%Forecast 0.7%Previous 1.1%
- November 17, 2026USDRetail Sales m/m●●●Actual 0.2%Forecast 0.3%Previous 0.8%
Coming up
- TodayUSDInitial Jobless Claims●●●in 2h
- TodayUSDPhiladelphia Fed Manufacturing Index●●●Forecast 32.2Previous 20.9in 2h
- TomorrowUSDMichigan Consumer Sentiment●●●Forecast 51.0Previous 51.0in 1 day
- November 24, 2026USDCB Consumer Confidence Index●●●Forecast 91.5Previous 91.7in 5 days
- November 25, 2026USDCore PCE Price Index m/m●●●Forecast 0.3%Previous 0.3%in 6 days
- November 25, 2026USDGDP Sales q/q●●●Forecast 1.7%Previous 1.7%in 6 days
- November 25, 2026USDGDP q/q●●●Forecast 3.4%Previous 3.4%in 6 days
- November 25, 2026USDDurable Goods Orders m/m●●●Forecast -0.7%Previous 1.8%in 6 days
All times UTC. Assessed against the consensus forecast, otherwise against the previous value.
Both worlds over time
Technical and news signals of the last 90 days on one timeline.
What is being reported about PLAG
Frequently asked questions about Planet Green Holdings
What did Planet Green just announce?
Subsidiary Taihe Bio agreed with Harbin Aikesailun Biotechnology to acquire the formulation, production technology and Chinese health food registration rights for a lactoferrin, bovine colostrum and vitamin C chewable tablet. The 8-K filing gave no purchase price, revenue figures or guidance, and the registration transfer still needs SAMR approval.
Why is the verdict neutral when there is fresh news?
The deal is strategic but unquantified: without a disclosed purchase price or any financial guidance, there is no way to say whether it adds or destroys value. It also depends on a pending regulatory approval. With no trading history available to provide a technical check, the balanced label simply reflects what can honestly be concluded.
What should I watch from here?
The joint application to China's SAMR to move the health food registration certificate to Taihe Bio is the near-term milestone, and any disclosure of the deal's financial terms would change the picture. Broader US data due in the coming days, including inflation and consumer readings, sets the backdrop for smaller listed companies.
📝 Overview Generated automatically
PLAG has been the subject of 2 signals across 2 articles in the last 365 days. Sentiment skews Neutral (100%).
Breakdown: 0 bullish, 0 bearish, 2 neutral.
Most-cited catalysts: Execution of a material definitive agreement as disclosed in Item 1.01 of the 8-K filing. (1×), Technology transfer agreement with Harbin Aikesailun Biotechnology announced November 17, 2026 (1×), Pending joint application to SAMR to transfer the Chinese health food registration certificate to Taihe Bio (1×). Most-cited risk factors: Lack of transparency regarding the specific terms and counter-parties of the agreement. (1×), Potential for the agreement to fail or be terminated before full implementation. (1×), No purchase price or financial terms are disclosed, so the cost and expected return are unknown (1×).